Chapter 347: Chapter 326: Treated as a Confidant

Although he said Zhao Heng was drafted, Liu Ziang’s face bore a smile. To Liu Ziang, Zhao Heng is a rare confidant.

For a genius like Liu Ziang, finding a friend like Zhao Heng is exceptionally difficult.

The more of a genius one is, the more demanding they are about communication efficiency, which results in Liu Ziang having little interest in conversing with those who can’t keep up with his thoughts.

Hence, Liu Ziang particularly cherishes Zhao Heng’s friendship.

“Junior, what are your thoughts on the current medication for the patient?”

Liu Ziang asked Zhao Heng.

Although he wasn’t sure how Zhao Heng improved his skills, Liu Ziang knew Zhao Heng’s expertise is very high. Even in Liu Ziang’s specialty, neurosurgery, Zhao Heng’s level is on par with his. Consequently, Liu Ziang serves a complementary role to Zhao Heng.

With external assistance that integrates the experiences of almost all the great doctors at Eastern Hospital, it doesn’t mean Zhao Heng is omnipotent. No matter how brilliant, everyone has blind spots in thinking.

“Currently, I’m considering using Bevacizumab. Once this batch of carbon nanotubes is prepared, Bevacizumab can be loaded onto it, thus sustaining until the siRNA colloidal beam is developed.”

Zhao Heng pondered and spoke.

Bevacizumab is a recombinant humanized immunoglobulin G1 (IgG1) monoclonal antibody that can bind with VEGF-A, inhibiting its binding to the VEGF receptor-2 (VEGFR-2), thereby suppressing VEGF’s biological effects, including influencing vascular permeability, proliferation, and endothelial cell migration and survival, achieving the effect of inhibiting tumor angiogenesis, growth, and metastasis.

“Yes, Bevacizumab can normalize tumor blood vessels, improve vascular permeability, increase the effective drug concentration in tumor tissue, and exert its anti-tumor effects. It is indeed one of the better choices currently.”

“On the basis of choosing Bevacizumab, care must be taken to prevent complications and side effects.”

Liu Ziang advised.

The treatment plan proposed by Zhao Heng was essentially Liu Ziang’s suggestion too. Their thoughts were quite aligned, but in actual treatment, Liu Ziang, being the original expert, surely has more experience in finer details.

“Hmm.”

Zhao Heng nodded.

“By the way, what treatments did Ma Xiaochen receive at Mayo Clinic that caused his condition to worsen?”

Liu Ziang suddenly asked.

“They suggested surgery over there, but Ma Xiaochen’s family disagreed, so it’s been dragging on.”

Zhao Heng said.

“Even if it’s not surgery, dragging isn’t a solution. Moreover, for malignant brain gliomas, any treatment method currently causes damage to the patient’s body.”

Liu Ziang remarked with some contemplation.

He could somewhat understand why Ma Xiaochen’s treatment was prolonged after surgery was ruled out; the fundamental reason lies in the treatment of brain glioma. Currently, every treatment method, whether chemotherapy or radiotherapy, causes damage to the patient’s body.

And the method that causes little or no damage is nanotherapy, but Liu Ziang knows Mayo Clinic focuses on surgical treatment, evident from their development of various high-precision surgical robots.

After all, compared to developing personalized nano-therapy agents, surgical robots are more versatile and have a broader range of applications as a means of treatment.

The development benefits are completely different too.

The treatment philosophies are entirely different between the East and the West.

Comparatively, the East emphasizes the overall condition of the patient, while the West is more inclined to treat the patient as separate parts.

“Everyone has their considerations. Currently, stabilizing the patient’s condition is still the top priority.”

Zhao Heng calmly said.

“Senior, please keep an eye on Ma Xiaochen. If you have any new thoughts on his treatment, let me know anytime.”

After a pause, Zhao Heng further addressed Liu Ziang.

In modern hospitals, patients’ clinical data, including real-time monitored physiological data and routine examination imaging data, are uploaded to terminals and accessible on each physician’s work tablet.

However, Zhao Heng still prefers reviewing films for imaging data.

So, as long as Zhao Heng grants Liu Ziang access to Ma Xiaochen’s clinical data, Liu Ziang can track the changes in Ma Xiaochen’s condition in real-time.

“Okay.”

Liu Ziang nodded.

The two chatted for a little while longer, then Liu Ziang returned to his department because he had tasks to attend to.

After Liu Ziang left, Liu Meng said to Zhao Heng with a sigh, “Dr. Zhao, if you and Director Liu join forces, is there any situation you wouldn’t be able to handle?”

Liu Ziang is already impressive enough and has always been the idol for resident doctors like Liu Meng. But now appearing suddenly, Zhao Heng seems even more impressive than Liu Ziang.

This made Liu Meng sigh, it truly is that talents emerge in every generation, each new wave replaces the old!

If she could reach even half the level of these two someday, it would be enough for her lifetime!

“We’re not deities…”

Hearing Liu Meng’s words, Zhao Heng replied somewhat helplessly.

He and Liu Ziang are far less formidable than everyone thinks. No matter how talented, one’s capabilities are always limited.

Source: Webnovel.com, updated by NovelKeep